Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: Identification of the c-myc regulatory gene network

BackgroundThe transcriptional regulator c-Myc is the most frequently deregulated oncogene in human tumors. Targeted overexpression of this gene in mice results in distinct types of lung adenocarcinomas. By using microarray technology, alterations in the expression of genes were captured based on a female transgenic mouse model in which, indeed, c-Myc overexpression in alveolar epithelium results in the development of bronchiolo-alveolar carcinoma (BAC) and papillary adenocarcinoma (PLAC). In this study, we analyzed exclusively the promoters of induced genes by different in silico methods in order to elucidate the c-Myc transcriptional regulatory network.ResultsWe analyzed the promoters of 361 transcriptionally induced genes with respect to c-Myc binding sites and found 110 putative binding sites in 94 promoters. Furthermore, we analyzed the flanking sequences (+/- 100 bp) around the 110 c-Myc binding sites and found Ap2, Zf5, Zic3, and E2f binding sites to be overrepresented in these regions. Then, we analyzed the promoters of 361 induced genes with respect to binding sites of other transcription factors (TFs) which were upregulated by c-Myc overexpression. We identified at least one binding site of at least one of these TFs in 220 promoters, thus elucidating a potential transcription factor network. The analysis correlated well with the significant overexpression of the TFs Atf2, Foxf1a, Smad4, Sox4, Sp3 and Stat5a. Finally, we analyzed promoters of regulated genes which where apparently not regulated by c-Myc or other c-Myc targeted TFs and identified overrepresented Oct1, Mzf1, Ppargamma, Plzf, Ets, and HmgIY binding sites when compared against control promoter background.ConclusionOur in silico data suggest a model of a transcriptional regulatory network in which different TFs act in concert upon c-Myc overexpression. We determined molecular rules for transcriptional regulation to explain, in part, the carcinogenic effect seen in mice overexpressing the c-Myc oncogene.

[1]  Jonathan D. Licht,et al.  Growth Suppression by Acute PromyelocyticLeukemia-Associated Protein PLZF Is Mediated by Repression ofc-mycExpression , 2003, Molecular and Cellular Biology.

[2]  Andrew I Su,et al.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. , 2002, The American journal of pathology.

[3]  N. Lee,et al.  Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.

[4]  Rajnish A. Gupta,et al.  Controversy: PPARγ as a target for treatment of colorectal cancer , 2002 .

[5]  David Levens,et al.  Disentangling the MYC web , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Brough,et al.  An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation , 1995, Molecular and cellular biology.

[8]  Jing Gao,et al.  Integration of Genome and Chromatin Structure with Gene Expression Profiles To Predict c-MYC Recognition Site Binding and Function , 2007, PLoS Comput. Biol..

[9]  Danielle Hulsman,et al.  Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice , 2002, Nature Genetics.

[10]  G. Stein,et al.  Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. , 1995, Biochemistry.

[11]  John D. Watson,et al.  Identifying Genes Regulated in a Myc-dependent Manner* , 2002, The Journal of Biological Chemistry.

[12]  K. Kaestner,et al.  Unified nomenclature for the winged helix/forkhead transcription factors. , 2000, Genes & development.

[13]  S. R. Hann,et al.  Myc-mediated transformation: the repression connection , 1999, Oncogene.

[14]  Stella Pelengaris,et al.  c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.

[15]  Toshiyuki Yamada,et al.  Molecular biology of the Ets family of transcription factors. , 2003, Gene.

[16]  G. Suske,et al.  Transcription factor Sp3 is regulated by acetylation. , 2001, Nucleic acids research.

[17]  Yigong Shi,et al.  Transforming Growth Factor (cid:2) -Mediated Transcriptional Repression of c- myc Is Dependent on Direct Binding of Smad3 to a Novel Repressive Smad Binding Element , 2022 .

[18]  Annick Harel-Bellan,et al.  The Retinoblastoma Protein Binds the Promoter of the Survival Gene bcl-2 and Regulates Its Transcription in Epithelial Cells through Transcription Factor AP-2 , 2002, Molecular and Cellular Biology.

[19]  L. Resar,et al.  HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene , 2000, Molecular and Cellular Biology.

[20]  Paul J. Scotting,et al.  Differential Expression of SOX4 and SOX11 in Medulloblastoma , 2002, Journal of Neuro-Oncology.

[21]  P. Sharp,et al.  The octamer binding transcription factor Oct-1 is a stress sensor. , 2005, Cancer research.

[22]  L. Lim,et al.  Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[23]  K. Zhao,et al.  SAR‐dependent mobilization of histone H1 by HMG‐I/Y in vitro: HMG‐I/Y is enriched in H1‐depleted chromatin. , 1993, The EMBO journal.

[24]  Zhiping Weng,et al.  Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.

[25]  Adam A. Margolin,et al.  Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.

[26]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[27]  Lene Rask,et al.  Astroglial c-Myc Overexpression Predisposes Mice to Primary Malignant Gliomas* , 2003, The Journal of Biological Chemistry.

[28]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D Remondini,et al.  Targeting c-Myc-activated genes with a correlation method: detection of global changes in large gene expression network dynamics. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[31]  M. Rubin,et al.  Prostatic neoplasia in transgenic mice with prostate‐directed overexpression of the c‐myc oncoprotein , 2000, The Prostate.

[32]  Amy S. Lee,et al.  YY1 as a Regulator of Replication-dependent Hamster Histone H3.2 Promoter and an Interactive Partner of AP-2* , 2001, The Journal of Biological Chemistry.

[33]  S. Yamamoto,et al.  Genomic cloning and characterization of the mouse POZ/zinc-finger protein ZF5. , 1998, Biochemical and biophysical research communications.

[34]  S. Jeong,et al.  Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A2/delta12-PGJ2 in Hep3B cells. , 1999, Biochemical and biophysical research communications.

[35]  Michael C O'Donovan,et al.  Experimental analysis of the annotation of promoters in the public database. , 2002, Human molecular genetics.

[36]  Rosalie C Sears,et al.  Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.

[37]  F. Naef,et al.  Identifying synergistic regulation involving c-Myc and sp1 in human tissues , 2007, Nucleic acids research.

[38]  E. Wingender,et al.  MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.

[39]  S. Ishihara,et al.  Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists , 2000, British Journal of Cancer.

[40]  Michael Q. Zhang,et al.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N Barker,et al.  Ligand activation of peroxisome proliferator-activated receptor γ induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity , 2002, Cell Death and Differentiation.

[42]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[43]  K. Klempnauer,et al.  Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2 , 2001, Oncogene.

[44]  Tien Hsu,et al.  Ets proteins in biological control and cancer , 2004, Journal of cellular biochemistry.

[45]  Chi V. Dang,et al.  A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Farnham,et al.  Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. , 1994, Genes & development.

[47]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[48]  John M Sedivy,et al.  Stress response gene ATF3 is a target of c‐myc in serum‐induced cell proliferation , 2005, The EMBO journal.

[49]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  U. Weidle,et al.  The transcriptional program of a human B cell line in response to Myc. , 2001, Nucleic acids research.

[51]  M Schwab,et al.  N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis , 2001, The EMBO journal.

[52]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[53]  E. Prochownik,et al.  Genetic dissection of c-myc apoptotic pathways , 2000, Oncogene.

[54]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[55]  T. Kouzarides,et al.  Myc represses transcription through recruitment of DNA methyltransferase corepressor , 2005, The EMBO journal.

[56]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[57]  M. Abdelrahim,et al.  Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells , 2004, Cancer Research.

[58]  K. Kamiya,et al.  Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. , 1993, Nucleic acids research.

[59]  N. Benvenisty,et al.  A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors , 2001, Oncogene.

[60]  Michael Bustin,et al.  Dynamic interaction of HMGA1a proteins with chromatin , 2004, Journal of Cell Science.

[61]  J. Whitlock,et al.  Induction of cytochrome P4501A1. , 1999, Annual review of pharmacology and toxicology.

[62]  E. Wagner,et al.  AP-1 – Introductory remarks , 2001, Oncogene.

[63]  A Ma,et al.  E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice. , 1991, Oncogene.

[64]  M. Birrer,et al.  Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[65]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[66]  Johan Auwerx,et al.  Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects , 1998, Diabetes.

[67]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[68]  Dimitris Thanos,et al.  Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y) , 1995, Cell.

[69]  Xin Chen,et al.  The TRANSFAC system on gene expression regulation , 2001, Nucleic Acids Res..

[70]  R. Shamir,et al.  In silico identification of transcriptional regulators associated with c-Myc. , 2004, Nucleic acids research.

[71]  H. G. van der Poel,et al.  A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. , 1996, British Journal of Cancer.

[72]  Yutaka Satou,et al.  Multiple functions of a Zic-like gene in the differentiation of notochord, central nervous system and muscle in Ciona savignyi embryos. , 2002, Development.

[73]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[74]  P. Carlsson,et al.  FREAC-1 contains a cell-type-specific transcriptional activation domain and is expressed in epithelial-mesenchymal interfaces. , 1998, Developmental biology.

[75]  K. Calame,et al.  The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. , 1997, Nucleic acids research.

[76]  Kathryn A. O’Donnell,et al.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.

[77]  Michael McClelland,et al.  Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. , 2004, Molecular cell.

[78]  Rajnish A. Gupta,et al.  Controversy: PPARgamma as a target for treatment of colorectal cancer. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[79]  F. Hoffmann,et al.  Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-β signaling , 2006, Proceedings of the National Academy of Sciences.

[80]  A. Menssen,et al.  Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S Gaubatz,et al.  Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.

[82]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.